You can stop cringing every time you add a bottle of Olaplex or Glossier Cloud Paint to your cart — because these cheaper ...
CleanTok has us in the cleaning mood! Here are cleaning products from TikTok that are worth your money and where to shop them ...
As winter germ season peaks, Chuck Crawford, Ph.D., Chief Innovation Officer at GOJO, MAKERS OF PURELLâ„¢, offers these five ...
A research team has discovered that by using a new method of "atomic spray painting," they can tweak the atomic structure of lead-free potassium niobate in order to enhance its ferroelectric ...
Las Vegas, NV, January 28, 2025-The International Surfaces Event (TISE)/Surfaces begins today in Las Vegas, Nevada at the Mandalay Bay, running through January 30. Surfaces is the largest ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Taylor Swift went 2-for-2 on Sunday night after watching Travis Kelce and the Kansas City Chiefs secure the AFC Championship. The "Karma" singer was in attendance for the AFC title game as well ...
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
Microsoft is set to reveal new devices in 2025, including a Surface Pro and Surface Laptop with smaller designs and Snapdragon X power, according to a recent report. Better yet, they're expected ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...